| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pliant Therapeutics, Inc. (PLRX) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 6 sells. PLRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 505.6K | $586.5K | - | |
| CFO | 297.2K | $344.8K | - | |
| Other | 44.8K | $52.0K | - | |
| COO | 37.8K | $43.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | Coulie Bernard80 | President And CEO | Sell | 3,500 | $27.37 | $95,790.16 | -0.4% | |
| Dec 1, 2020 | Cummings Keith Lamont74 | Chief Financial Officer | Sale+OE | 18,734 | $30.00 | $562,035.05 | -15.4% |